Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Pacific Biosciences (PACB)

Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 518,838
  • Shares Outstanding, K 272,356
  • Annual Sales, $ 200,520 K
  • Annual Income, $ -306,740 K
  • 60-Month Beta 2.05
  • Price/Sales 2.55
  • Price/Cash Flow N/A
  • Price/Book 0.78
Trade PACB with:

Options Overview Details

View History
  • Implied Volatility 133.15% ( +4.51%)
  • Historical Volatility 135.01%
  • IV Percentile 88%
  • IV Rank 62.89%
  • IV High 182.18% on 07/01/24
  • IV Low 50.05% on 09/01/23
  • Put/Call Vol Ratio 0.13
  • Today's Volume 2,648
  • Volume Avg (30-Day) 2,877
  • Put/Call OI Ratio 0.27
  • Today's Open Interest 103,899
  • Open Int (30-Day) 96,971

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.24
  • Number of Estimates 4
  • High Estimate -0.21
  • Low Estimate -0.26
  • Prior Year -0.26
  • Growth Rate Est. (year over year) +7.69%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1600 +83.62%
on 07/02/24
2.2400 -4.91%
on 07/16/24
+0.7800 (+57.20%)
since 06/26/24
3-Month
1.1600 +83.62%
on 07/02/24
2.6700 -20.22%
on 05/14/24
+0.6600 (+44.90%)
since 04/26/24
52-Week
1.1600 +83.62%
on 07/02/24
13.7000 -84.45%
on 07/27/23
-11.0500 (-83.84%)
since 07/26/23

Most Recent Stories

More News
Pacific Biosciences: Q1 Earnings Snapshot

Pacific Biosciences: Q1 Earnings Snapshot

PACB : 2.1300 (+11.81%)
Pacific Biosciences: Q4 Earnings Snapshot

Pacific Biosciences: Q4 Earnings Snapshot

PACB : 2.1300 (+11.81%)
Pacific Biosciences: Q3 Earnings Snapshot

Pacific Biosciences: Q3 Earnings Snapshot

PACB : 2.1300 (+11.81%)
Cathie Wood Just Added $5 Million of This Stock After It Had a Steep Pullback. Is It a No-Brainer Buy?

This innovator is targeting a huge, rapidly growing market.

PACB : 2.1300 (+11.81%)
ARKK : 45.78 (+1.31%)
ARKG : 27.23 (+2.02%)
PacBio Announces Appointment of David Meline to Board of Directors

/PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the appointment of David...

PACB : 2.1300 (+11.81%)
PacBio to Report Third Quarter 2023 Financial Results on October 30, 2023

/PRNewswire/ -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its third quarter 2023 financial results on...

PACB : 2.1300 (+11.81%)
PacBio Announces Complete Computational Workflow for Human Whole Genome Sequencing Data Analysis

/PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the availability of PacBio...

PACB : 2.1300 (+11.81%)
Cathie Wood's Buying These 3 Stocks Hand Over Fist

A drugmaker, a gene sequencer, and a streaming business all made deep impressions on Ark Invest's stock-picking team.

AAPL : 217.96 (+0.22%)
ILMN : 120.43 (+2.67%)
BEAM : 33.14 (+3.02%)
PACB : 2.1300 (+11.81%)
SPOT : 321.88 (-2.15%)
PacBio Announces Collaboration with Leading Library Preparation Automation Partners

/PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced that automation providers...

PACB : 2.1300 (+11.81%)
PacBio to Present at Upcoming Investor Conferences

/PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be...

PACB : 2.1300 (+11.81%)

Business Summary

Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time...

See More

Key Turning Points

3rd Resistance Point 2.4400
2nd Resistance Point 2.3100
1st Resistance Point 2.2200
Last Price 2.1300
1st Support Level 2.0000
2nd Support Level 1.8700
3rd Support Level 1.7800

See More

52-Week High 13.7000
Fibonacci 61.8% 8.9100
Fibonacci 50% 7.4300
Fibonacci 38.2% 5.9500
Last Price 2.1300
52-Week Low 1.1600

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar